The company has volume of 6.57 Million shares. After a recent spot-check, the stock has touched $63.97 which represents a change from the open of 1.86%. The medical instruments supplier reported $0.70 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.66 by $0.04. Ltd. now owns 35,614 shares of the medical instruments supplier's stock worth $2,130,000 after buying an additional 1,111 shares during the last quarter. LLC purchased a new stake in shares of DENTSPLY SIRONA during the third quarter valued at $124,000. Commonwealth Bank of Australia now owns 1,626 shares of the medical instruments supplier's stock worth $104,000 after purchasing an additional 260 shares during the last quarter.
DENTSPLY SIRONA Inc, formerly DENTSPLY International Inc, designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. Stifel Nicolaus upped their price target on shares of DENTSPLY SIRONA from $66.00 to $70.00 and gave the stock a "buy" rating in a research report on Monday, November 6th. Thompson Siegel & Walmsley LLC boosted its stake in shares of DENTSPLY SIRONA by 41.4% during the 3rd quarter. Veritas Asset Management LLP now owns 5,432,428 shares of the company's stock worth $322,849,000 after buying an additional 109,722 shares during the period. The stock traded with the volume of 6.62 Million shares yesterday. Briefly looking at some recent volatility numbers, we can see that shares have been noted at 1.25% for the week, and 1.40% for the past month.
DENTSPLY SIRONA Inc. (NASDAQ:XRAY), stock is trading $68.98 above the 52-week high and has displayed a high EPS growth of 2.60% in last 5 years. The firm has "Outperform" rating by Barrington Research given on Monday, December 5. Finally, Stephens assumed coverage on DENTSPLY SIRONA in a research report on Tuesday, November 28th. JPMorgan Chase & Co. upgraded shares of DENTSPLY SIRONA from a "neutral" rating to an "overweight" rating and set a $75.00 price target for the company in a report on Wednesday, December 13th. Analysts set a 12-month price target of $4.04 a share. Finally, BidaskClub cut shares of DENTSPLY SIRONA from a "strong-buy" rating to a "buy" rating in a report on Saturday, December 2nd. The direction of this stock is getting Strongest.This is an indicator for investors to know whether the stock is heading towards a Buy or Sell, or whether the Hold is advancing towards a Buy or a Sell.
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) has been trading in a bullish manner, based on the relative positions of the stock's 20 and 200 day moving averages.
Returns and Valuations for DENTSPLY SIRONA Inc. About 8.77M shares traded or 26.58% up from the average. The current consensus recommendation provided by covering analysts is 2.00. The firm has a market capitalization of $13.06 billion, a PE ratio of 29.56 and a beta of 1.23. Over the course of a year, the highest point for this stock was at $22.10 while the lowest price during that same timeframe was $12.00. DENTSPLY International Inc. (NASDAQ:XRAY) has a 20-Day average volume of 1.63 Million. The Return on Equity (ROE) value stands at -10.2%. The business had revenue of $1.01 billion for the quarter, compared to analyst estimates of $978.99 million.
Cypress Semiconductor Corporation (CY) have shown a high EPS growth of -34.40% in the last 5 years and has earnings decline of -71.20% yoy. On average, equities analysts forecast that DENTSPLY SIRONA Inc. will post $2.76 earnings per share for the current year.
The business also recently announced a quarterly dividend, which was paid on Friday, January 13th. This represents a $0.35 dividend on an annualized basis and a dividend yield of 0.56%. DENTSPLY SIRONA's dividend payout ratio is now -10.06%.
In other DENTSPLY SIRONA news, Director Eric Brandt sold 6,409 shares of the firm's stock in a transaction on Monday, January 8th. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The shares were sold at an average price of $65.90, for a total transaction of $586,510.00. The disclosure for this purchase can be found here. Yost Capital Management Llc bought 124,914 shares as the company's stock rose 17.48% with the market.
TRADEMARK VIOLATION NOTICE: This story was reported by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are accessing this piece on another website, it was copied illegally and reposted in violation of U.S. and global copyright and trademark legislation. The stock of DENTSPLY SIRONA Inc. Its sales stood at 14.10% a year on average in the period of last five years. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
- (COST) Shares Sold by Ashfield Capital Partners LLC
- Sushma Swaraj arrives in Thailand
- O'Neill and Keane in line to make Stoke move
- 'Black Widow' standalone movie finds writer in Jac Schaeffer
- UK says limit kids to 2 sugary snacks
- Grandparents who claimed pot was meant for Christmas gifts arrested again
- Police hilariously warn against 'highly addictive' Girl Scout cookies
- Priyanka Chopra to return with "Quantico" on April 26
- 'Dangerously cold' wind chills threaten millions from Great Lakes to New England
- Near term Outlook For Oasis Petroleum Inc. (NYSE:OAS)